Search Results - "Ghetie, V"

Refine Results
  1. 1

    Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin’s lymphoma by Schnell, R., Borchmann, P., Staak, J. O., Schindler, J., Ghetie, V., Vitetta, E. S., Engert, A.

    Published in Annals of oncology (01-05-2003)
    “…Background: Immunotoxins (ITs) consist of cell binding ligands coupled to toxins or their subunits. Hodgkin’s lymphoma (HL) is an excellent target for ITs…”
    Get full text
    Journal Article
  2. 2

    Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells by Antohe, Felicia, Rădulescu, Luminiţa, Gafencu, Anca, Gheţie, Victor, Simionescu, Maya

    Published in Human immunology (01-02-2001)
    “…The mechanism of selective transport of the immunoglobulins G from the placental stroma to the lumen of the fetal blood vessels has not been elucidated yet. It…”
    Get full text
    Journal Article
  3. 3

    Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1 by Medesan, C, Matesoi, D, Radu, C, Ghetie, V, Ward, ES

    Published in The Journal of immunology (1950) (01-03-1997)
    “…The MHC class I-related receptor, FcRn, is involved in both the transcytosis of serum gamma-globulins (IgGs) and in regulating their serum persistence. The…”
    Get full text
    Journal Article
  4. 4

    Treatment of SCID human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins by HERRERA, L, YARBROUGH, S, GHETIE, V, AQUINO, D. B, VITETTA, E. S

    Published in Leukemia (01-02-2003)
    “…The anti-CD19 (HD37-dgRTA) and anti-CD22 (RFB4-dgRTA) immunotoxins (ITs) are murine IgG(1) monoclonal antibodies (Mabs) conjugated to a deglycosylated ricin A…”
    Get full text
    Journal Article
  5. 5

    Anti-CD19 immunotoxin enhances the activity of chemotherapy in severe combined immunodeficient mice with human pre-B acute lymphoblastic leukemia by Herrera, L., Stanciu-Herrera, C., Morgan, C., Ghetie, V., Vitetta, E. S.

    Published in Leukemia & lymphoma (01-11-2006)
    “…The anti-CD19 immunotoxin (IT) (HD37-dgRTA) is effective in killing B-lineage leukemia cells and in curing severe combined immunodeficient mice with acute…”
    Get full text
    Journal Article
  6. 6

    Treatment of refractory Hodgkin's lymphoma patients with an anti-CD25 ricin A-chain immunotoxin by SCHNELL, R, VITETTA, E, SCHINDLER, J, BORCHMANN, P, BARTH, S, GHETIE, V, HELL, K, DRILLICH, S, DIEHL, V, ENGERT, A

    Published in Leukemia (01-01-2000)
    “…The anti-CD25 immunotoxin RFT5.dgA was constructed by coupling the monoclonal antibody RFT5 via a sterically hindered disulfide linker to deglycosylated ricin…”
    Get full text
    Journal Article
  7. 7

    A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy by AMLOT, P. L, STONE, M. J, RAMILO, O, THORPE, P. E, UHR, J. W, VITETTA, E. S, CUNNINGHAM, D, FAY, J, NEWMAN, J, COLLINS, R, MAY, R, MCCARTHY, M, RICHARDSON, J, GHETIE, V

    Published in Blood (01-11-1993)
    “…Twenty-six patients, whose B-cell lymphoma had relapsed after conventional therapies, were treated in a phase I dose escalation study with an immunotoxin…”
    Get full text
    Journal Article
  8. 8

    Chemical construction of immunotoxins by GHETIE, Victor, VITETTA, Ellen S

    Published in Molecular biotechnology (01-07-2001)
    “…Immunotoxins are chimeric proteins consisting of an antibody linked to a toxin. The antibodies most frequently used for the preparation of immunotoxins are…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Clinical Trials with an Anti-CD25 Ricin A-Chain Experimental and Immunotoxin (RFT5-SMPT-dgA) in Hodgkin's Lymphoma by Schnell, R., Vitetta, E., Schindler, J., Barth, S., Winkler, U., Borchmann, P., Hansmann, M. L., Diehl, V., Ghetie, V., Engert, A.

    Published in Leukemia & lymphoma (01-08-1998)
    “…Immunotoxins (ITs) consisting of a cell-binding component and a potent toxin were developed as a new class of biological anti-tumor agents to improve adjuvant…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    The effector functions of immunoglobulins: implications for therapy by Ward, E S, Ghetie, V

    Published in Therapeutic immunology (01-04-1995)
    “…The effector functions of immunoglobulins of the G class (IgGs) are essential for their effective use in therapy. The functions that operate following complex…”
    Get more information
    Journal Article
  14. 14

    Multiple Roles for the Major Histocompatibility Complex Class I- Related Receptor FcRn by Ghetie, Victor, Ward, E. Sally

    Published in Annual review of immunology (01-01-2000)
    “…Multiple functions have recently been identified for the neonatal Fc receptor FcRn. In addition, a human homolog of the rodent forms of FcRn has been…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Differences in promiscuity for antibody–FcRn interactions across species: implications for therapeutic antibodies by Ober, Raimund J., Radu, Caius G., Ghetie, Victor, Ward, E. Sally

    Published in International immunology (01-12-2001)
    “…Preclinical tests of therapeutic antibodies are frequently carried out in mice to evaluate pharmacokinetics and efficacy. However, the observation that mouse…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans by Firan, Mihail, Bawdon, Roger, Radu, Caius, Ober, Raimund J., Eaken, Darla, Antohe, Felicia, Ghetie, Victor, Ward, E. Sally

    Published in International immunology (01-08-2001)
    “…The transfer of maternal γ-globulin (IgG) provides the neonate with humoral immunity during early life. In humans, maternal IgG is transported across the…”
    Get full text
    Journal Article
  20. 20

    Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans by Ward, E. Sally, Zhou, Jinchun, Ghetie, Victor, Ober, Raimund J.

    Published in International immunology (01-02-2003)
    “…IgG is the most abundant serum antibody and is an essential component of the humoral immune response. It is known that the ‘neonatal’ Fc receptor (FcRn) plays…”
    Get full text
    Journal Article